Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -358.08x is 83% above its 5-year average of -2124.91x, near the high end of its 5-year range (-32480.00x–-16.37x).
3.96% below its 12-month average of -344.45x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -436.79x.
INTEREST COVERAGE RATIO
-358.08x
INTEREST COVERAGE RATIO AVG TTM
-344.45x
INTEREST COVERAGE RATIO AVG 3Y
-1519.85x
INTEREST COVERAGE RATIO AVG 5Y
-2124.91x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-3.96%
CURRENT VS 3Y AVG
+76.44%
CURRENT VS 5Y AVG
+83.15%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
6.80x
median of 88 covered companies
CURRENT VS SECTOR MEDIAN
-5365.88%
vs the sector median at left
Recursion Pharmaceuticals, Inc.
Market Cap
$2.13B
Interest Coverage Ratio
-358.08x
TTM Avg
-344.45x
3Y Avg
-1519.85x
5Y Avg
-2124.91x
Market Cap
$2.49B
Interest Coverage Ratio
-8.77x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.74B
Interest Coverage Ratio
2.86x
TTM Avg
2.86x
3Y Avg
2.86x
5Y Avg
6.42x
Market Cap
$1.71B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.72B
Interest Coverage Ratio
7.88x
TTM Avg
5.24x
3Y Avg
5.24x
5Y Avg
5.24x
Market Cap
$1.01B
Interest Coverage Ratio
-13.34x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$470.35M
Interest Coverage Ratio
-17.61x
TTM Avg
2.56x
3Y Avg
1.47x
5Y Avg
1.63x
Market Cap
$459.30M
Interest Coverage Ratio
4.74x
TTM Avg
9.15x
3Y Avg
25.82x
5Y Avg
26.16x
Market Cap
$389.98M
Interest Coverage Ratio
-375.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Recursion Pharmaceuticals, Inc. (RXRX) | $2.13B | -358.08x | -344.45x | -1519.85x | -2124.91x |
| Beam Therapeutics Inc. (BEAM)vs › | $2.49B | -8.77x | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 2.86x | 2.86x | 2.86x | 6.42x |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 7.88x | 5.24x | 5.24x | 5.24x |
| Teladoc Health, Inc. (TDOC)vs › | $1.01B | -13.34x | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $470.35M | -17.61x | 2.56x | 1.47x | 1.63x |
| NRC Health (NRC)vs › | $459.30M | 4.74x | 9.15x | 25.82x | 26.16x |
| Shoulder Innovations, Inc. (SI)vs › | $389.98M | -375.67x | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $41.24M | -5.91x | N/A | N/A | N/A |
Interest Coverage
-358.1x
Debt/Equity
0.07
Current Ratio
5.03
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -436.79x |
| 2026-03-31 | -367.16x |
| 2025-09-30 | -206.73x |
| 2025-06-30 | -367.14x |
| 2025-03-31 | -376.71x |
| 2024-12-31 | -303.75x |
| 2024-09-30 | -177.86x |
| 2024-06-30 | -255.19x |
| 2024-03-31 | -4817.00x |
| 2023-12-31 | -3805.00x |
| 2023-09-30 | -3982.00x |
| 2023-06-30 | -3142.88x |
| 2023-03-31 | -3677.11x |
| 2022-12-31 | -4690.92x |
| 2022-09-30 | -4813.31x |
| 2022-06-30 | -4727.93x |
| 2022-03-31 | -3998.64x |
| 2021-12-31 | -32480.00x |
| 2021-09-30 | -210.92x |
| 2021-06-30 | -16.37x |
| 2021-03-31 | -122.43x |
| 2020-12-31 | -110.74x |
| 2020-09-30 | -56.04x |
| 2020-06-30 | -42.76x |
| 2020-03-31 | -60.94x |
